Jul 29, 2026 04:05PM

May 13, 2026 08:30AM

Mar 26, 2026 08:13AM

Aug 28, 2025 04:30PM

Aug 19, 2025 01:20PM

Jul 23, 2025 04:05PM

Jun 25, 2025 09:45AM Morgan Stanley on Viking (VKTX): 'we view initiation of large Ph3 studies on schedule as an incremental positive'

Sep 30, 2024 06:03AM

Sep 12, 2024 06:56AM

Aug 28, 2024 04:03PM

Jul 24, 2024 04:05PM

Jun 27, 2024 03:21AM

Mar 4, 2024 04:45PM

Feb 28, 2024 08:53PM Viking Therapeutics (VKTX) Announces Pricing of $550 Mln Public Offering of Common Stock

Feb 28, 2024 08:50PM

Feb 27, 2024 04:20PM

Feb 27, 2024 04:19PM

Jul 27, 2022 04:05PM

Sep 2, 2020 04:30PM

Jul 29, 2020 04:05PM

Aug 28, 2019 07:30AM Viking Therapeutics to Participate in Upcoming Investor Conferences

Aug 1, 2019 04:05PM

Apr 11, 2019 09:22AM

Mar 29, 2019 09:27AM

Mar 27, 2019 09:28AM

Mar 26, 2018 09:13AM

Jun 6, 2017 07:15AM

Jun 6, 2017 07:14AM Viking Therapeutics Announces Promising Top Line Results from In Vivo Study of VK2809 in Non-Alcoholic Steatohepatitis (NASH)

May 24, 2016 10:24AM

May 24, 2016 09:27AM

Apr 8, 2016 09:30AM

224,650 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All